Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.
Authors
Dickinson, Peter DMalik, J
Mandall, Paula
Swindell, Ric
Bottomley, D
Hoskin, P
Logue, John P
Wylie, James P
Affiliation
Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.Issue Date
2014-05
Metadata
Show full item recordAbstract
To report the outcomes of >1000 men with low-risk prostate cancer treated with low-dose-rate (LDR) brachytherapy at three large UK cancer centres.Citation
Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK. 2014, 113 (5):748-53 BJU IntJournal
BJU InternationalDOI
10.1111/bju.12358PubMed ID
24053230Type
ArticleLanguage
enISSN
1464-410Xae974a485f413a2113503eed53cd6c53
10.1111/bju.12358
Scopus Count
Collections
Related articles
- Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience.
- Authors: Nobes JP, Wells IG, Khaksar SJ, Money-Kyrle JF, Laing RW, Langley SE
- Issue date: 2009
- (125)I brachytherapy in younger prostate cancer patients : Outcomes in low- and intermediate-risk disease.
- Authors: Kindts I, Stellamans K, Billiet I, Pottel H, Lambrecht A
- Issue date: 2017 Sep
- Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation.
- Authors: Ohashi T, Yorozu A, Saito S, Momma T, Toya K, Nishiyama T, Yamashita S, Shiraishi Y, Shigematsu N
- Issue date: 2013 Nov
- Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
- Authors: Mitchell DM, Swindell R, Elliott T, Wylie JP, Taylor CM, Logue JP
- Issue date: 2008 Jul
- Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy.
- Authors: Joseph J, Al-Qaisieh B, Ash D, Bottomley D, Carey B
- Issue date: 2004 Dec